Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...

Matthews blunder costs game, dead PP, and more: 3 reasons why Toronto Maple Leafs lost 4-3 in OT to Boston Bruins - Source: Imagn The Toronto Maple Leafs lost a tough OT matchup against the Boston ...

Daily ridership on Boston school buses has fallen by nearly 10,000 students over the past decade, while transportation spending has increased by tens of millions of dollars, according to a Globe ...

A pacemaker is a small, battery-powered device implanted in your chest to help regulate your heart rate. It consists of two main parts—a pulse generator and leads. Pulse generator: This contains the ...

Boston Scientific Corporation (NYSE ... which received FDA approval in the quarter and our EMPOWUR leadless pacemaker, which ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...